Clinical impact of misinterpretation of dual-energy X-ray absorptiometry during the evaluation of osteoporotic patients

References

• Meeta M, Harinarayan CV, Marwah R, et al. Clinical practice guidelines on postmenopausal osteoporosis: an executive summary and recommendations – Update 2019–2020. J Mid-Life Health. 2020;11(2):96–112.
   PubMedGoogle Scholar
• Lewiecki EM, Gordon CM, Baim S, et al. International Society for Clinical Densitometry 2007 adult and pediatric official positions. Bone. 2008;43(6):1115–1121.
   PubMed Web of Science ®Google Scholar
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Organ Tech Rep Ser. 1994;843:1–129.
   PubMed Web of Science ®Google Scholar
• Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–2381.
   PubMed Web of Science ®Google Scholar
• Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract. 2020;26(Suppl 1):1–46.
   PubMed Web of Science ®Google Scholar
• Burt VL, Harris T. The third National Health and Nutrition Examination Survey: contributing data on aging and health. Gerontologist. 1994;34(4):486–490.
   PubMed Web of Science ®Google Scholar
• Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467–475.
   PubMed Web of Science ®Google Scholar
• Miller PD, Zapalowski C, Kulak CAM, et al. Bone Densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab. 1999;84(6):1867–1871.
   PubMed Web of Science ®Google Scholar
• Rozenberg S, Bruyère O, Bergmann P, et al. How to manage osteoporosis before the age of 50. Maturitas. 2020;138:14–25.
   PubMed Web of Science ®Google Scholar
• Choksi P, Jepsen KJ, Clines GA. The challenges of diagnosing osteoporosis and the limitations of currently available tools. Clin Diabetes Endocrinol. 2018;29:4–12.
   Google Scholar
• Lewiecki EM, Binkley N, Morgan SL, et al. Best practices for dual-energy X-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry guidance. J Clin Densitom. 2016;19(2):127–140.
   PubMed Web of Science ®Google Scholar
• Leslie WD, Tsang JF, Caetano PA, et al. Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab. 2007;92(1):77–81.
   PubMed Web of Science ®Google Scholar
• Shuhart CR, Yeap SS, Anderson PA, et al. Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom. 2019;22(4):453–471.
   PubMed Web of Science ®Google Scholar
• Lewiecki EM, Bilezikian JP, Giangregorio L, et al. Proceedings of the 2018 Santa Fe Bone symposium: advances in the management of osteoporosis. J Clin Densitom. 2019;22(1):1–19.
   PubMed Web of Science ®Google Scholar
• Lenchik L, Rochmis P, Sartoris DJ. Optimized interpretation and reporting of dual X-ray absorptiometry (DXA) scans. Am J Roentgenol. 1998;171(6):1509–1520.
   PubMed Web of Science ®Google Scholar
• Sala A, Webber C, Halton J, et al. Effect of diagnostic radioisotopes and radiographic contrast media on measurements of lumbar spine bone mineral density and body composition by dual-energy X-ray absorptiometry. J Clin Densitom. 2006;9(1):91–96.
   PubMed Web of Science ®Google Scholar
• Lorente Ramos RM, Azpeitia Armán J, Arévalo Galeano N, et al. Dual energy X-ray absorptimetry: fundamentals, methodology, and clinical applications. Radiologia. 2012;54(5):410–423.
   PubMedGoogle Scholar
• Ferrari SL, Abrahamsen B, Napoli N, et al. Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int. 2018;29(12):2585–2596.
   PubMed Web of Science ®Google Scholar
• Buckley L, Guyatt G, Fink HA, et al. American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2017;69(8):1521–1537.
   PubMed Web of Science ®Google Scholar
• Martineau P, Leslie WD. Trabecular bone score (TBS): method and applications. Bone. 2017;104:66–72.
   PubMed Web of Science ®Google Scholar
• Palermo A, D'Onofrio L, Buzzetti R, et al. Pathophysiology of bone fragility in patients with diabetes. Calcif Tissue Int. 2017;100(2):122–132.
   PubMed Web of Science ®Google Scholar
• Dumic-Cule I, Ivanac G, Lucijanic T, et al. Type 2 diabetes and osteoporosis: current knowledge. Endocr Oncol Metab. 2018;4:23–29.
   Google Scholar
• Adami G, Gatti D, Rossini M, et al. Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort. Osteoporos Int. 2020;31(11):2113–2122.
   PubMed Web of Science ®Google Scholar
• Janghorbani M, Van Dam RM, Willett WC, et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007;166(5):495–505.
   PubMed Web of Science ®Google Scholar
• Naylor KL, Garg AX, Zou G, et al. Comparison of fracture risk prediction among individuals with reduced and normal kidney function. CJASN. 2015;10(4):646–653.
   PubMed Web of Science ®Google Scholar
• Nickolas TL, McMahon DJ, Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. JASN. 2006;17(11):3223–3232.
   Web of Science ®Google Scholar
• Bilezikian JP, Josse RG, Eastell R, et al. Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2013;98(4):1519–1528.
   PubMed Web of Science ®Google Scholar
• Watts NB, Bilezikian JP, Usiskin K, et al. Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2016;101(1):157–166.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Harvey NC, et al. A brief history of FRAX. Arch Osteoporos. 2018;13(1):118.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385–397.
   PubMed Web of Science ®Google Scholar
• El Miedany Y. FRAX: re-adjust or re-think. Arch Osteoporos. 2020;15(1):150.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Harvey NC, McCloskey E, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. 2020;31(1):1–12.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johansson H, Oden A, et al. Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int. 2011;22(3):809–816.
   PubMed Web of Science ®Google Scholar
• Leslie WD, Johansson H, McCloskey EV, et al. Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD Registry. J Bone Miner Res. 2018;33(11):1923–1930.
   PubMed Web of Science ®Google Scholar
• El Miedany Y, Toth M. Osteoporosis, fracture prevention and falls risk assessment –closing the gap between treatment guide- lines and clinical practice. Eur Musculoskelet Rev. 2011;6:14–17.
   Google Scholar
• Leslie WD, Morin SN, Lix LM, et al. Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture? Osteoporos Int. 2014;25(12):2817–2824.
   PubMed Web of Science ®Google Scholar
• Qiao D, Li Y, Liu X, et al. Association of obesity with bone mineral density and osteoporosis in adults: a systematic review and meta-analysis. Public Health. 2020;180:22–28.
   PubMed Web of Science ®Google Scholar
• Messina C, Buonomenna C, Menon G, et al. Fat mass does not increase the precision error of trabecular bone score measurements. J Clin Densitom. 2019;22(3):359–366.
   PubMed Web of Science ®Google Scholar
• Silva BC, Broy SB, Boutroy S, et al. Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD Official Positions Part 2: trabecular bone score. J Clin Densitom. 2015;18(3):309–330.
   PubMed Web of Science ®Google Scholar
• El-Desouki MI, Othman SM, Fouda MA. Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia. Saudi Med J. 2004;25(3):355–358.
   PubMed Web of Science ®Google Scholar
• Elbossaty WF. Mineralization of bones in osteoporosis and osteomalacia. Ann Clin Lab Res. 2017;05(04):201.
   Google Scholar
• Leib ES, Saag KG, Adachi JD, et al. Official Positions for FRAX® clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX® of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom. 2011;14(3):212–219.
   PubMed Web of Science ®Google Scholar
• Chiodini I, Francucci CM, Scillitani A. Densitometry in glucocorticoid-induced osteoporosis. J Endocrinol Invest. 2008;31(7 Suppl):33–37.
   PubMedGoogle Scholar
• Odén A, McCloskey EV, Kanis JA, et al. Burden of high fracture probability worldwide: secular increases 2010–2040. Osteoporos Int. 2015;26(9):2243–2248.
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–1733.
   PubMed Web of Science ®Google Scholar
• Clynes MA, Westbury LD, Dennison EM, et al. International Society for Clinical Densitometry (ISCD) and the International Osteoporosis Foundation (IOF). Bone densitometry worldwide: a global survey by the ISCD and IOF. Osteoporos Int. 2020;31(9):1779–1786.
   PubMedGoogle Scholar
• Guglielmi G, Muscarella S, Bazzocchi A. Integrated imaging approach to osteoporosis: state-of-the-art review and update. Radiographics. 2011;31(5):1343–1364.
   PubMed Web of Science ®Google Scholar
• Link TM, Kazakia G. Update on imaging-based measurement of bone mineral density and quality. Curr Rheumatol Rep. 2020;22(5):13–24.
   PubMed Web of Science ®Google Scholar